Markel Corporation markets and underwrites specialty insurance products in the United States and internationally. The company has market cap of $15.70 billion. It operates through three divisions: U.S. It has a 243.29 P/E ratio. Insurance, International Insurance, and Reinsurance.
Johnson & Johnson (JNJ) formed double top with $147.75 target or 5.00% above today’s $140.71 share price. Johnson & Johnson (JNJ) has $378.02 billion valuation. The stock increased 0.10% or $0.14 during the last trading session, reaching $140.71. About 364,301 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since December 28, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.
Investors sentiment is 0.83 in Q3 2017. Its the same as in 2017Q2. It is flat, as 45 investors sold Johnson & Johnson shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Accredited holds 4,932 shares. Georgia-based Voya Inv Management Llc has invested 1.31% in Johnson & Johnson (NYSE:JNJ). Yorktown Management & Rech has invested 0.35% of its portfolio in Johnson & Johnson (NYSE:JNJ). Usca Ria Limited Liability Corporation invested 0.84% in Johnson & Johnson (NYSE:JNJ). Weaver C Barksdale Associate Inc has invested 1.68% of its portfolio in Johnson & Johnson (NYSE:JNJ). First Fiduciary Invest Counsel holds 3.34% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 140,593 shares. Bangor Natl Bank has 13,325 shares for 0.35% of their portfolio. Ameritas Inv Prtn reported 0.5% in Johnson & Johnson (NYSE:JNJ). 38,000 are held by Fire Grp Inc. Optimum has invested 0.62% in Johnson & Johnson (NYSE:JNJ). Trust Of Toledo Na Oh holds 1.12% or 34,029 shares. Loeb invested in 1.7% or 42,700 shares. Great West Life Assurance Can has 3.88M shares. Td Asset, a Ontario – Canada-based fund reported 3.12M shares. The Ohio-based Hengehold Cap Management Limited Liability Co has invested 0.63% in Johnson & Johnson (NYSE:JNJ).
Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 EPS, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62B for 20.45 P/E if the $1.72 EPS becomes a reality. After $1.90 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.
Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 13 have Buy rating, 5 Sell and 5 Hold. Therefore 57% are positive. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, July 10 by RBC Capital Markets. BMO Capital Markets maintained it with “Buy” rating and $145.0 target in Thursday, August 31 report. On Friday, July 14 the stock rating was maintained by Jefferies with “Hold”. The company was maintained on Wednesday, April 20 by Goldman Sachs. Jefferies maintained it with “Hold” rating and $145.0 target in Tuesday, August 15 report. The rating was maintained by Jefferies on Tuesday, March 15 with “Hold”. On Wednesday, July 19 the stock rating was maintained by UBS with “Buy”. BMO Capital Markets maintained it with “Buy” rating and $145.0 target in Thursday, October 5 report. The stock of Johnson & Johnson (NYSE:JNJ) has “Sell” rating given on Wednesday, August 2 by BTIG Research. Vetr downgraded the stock to “Strong-Buy” rating in Monday, August 31 report.
Broad Run Investment Management Llc holds 9.18% of its portfolio in Markel Corporation for 256,912 shares. Avenir Corp owns 97,673 shares or 8.97% of their US portfolio. Moreover, Lafayette Investments Inc. has 8.62% invested in the company for 21,698 shares. The Nebraska-based Lincoln Capital Llc has invested 8.58% in the stock. Akre Capital Management Llc, a Virginia-based fund reported 513,348 shares.
Since January 1, 0001, it had 0 insider purchases, and 14 sales for $6.87 million activity.
Analysts await Markel Corporation (NYSE:MKL) to report earnings on February, 14. They expect $8.55 earnings per share, down 6.15% or $0.56 from last year’s $9.11 per share. MKL’s profit will be $118.77M for 33.04 P/E if the $8.55 EPS becomes a reality. After $-18.82 actual earnings per share reported by Markel Corporation for the previous quarter, Wall Street now forecasts -145.43% EPS growth.